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Abstract
Objective. To test clinical pathways in a variety of Italian health care organizations in 2000–2002 to measure performance in
decreasing process and outcome variations.
Design. Creation of indicators, speciWc for each clinical pathway, to measure variations in the care processes and outcomes.
Pre- and post-analysis model to evaluate the possible effect of the clinical pathways on each indicator.
Setting. We tested the clinical pathways in six sites, each with different clinical pathways.
Results. Reductions in health care macro-variation phenomena ( length of stay, patient pathways, etc.) and in performance
micro-variation (variations in diagnostic and therapeutic prescriptions, protocol implementation, etc.) were shown in sites
where pathways were implemented successfully. A signiWcant improvement in outcome for patients who were treated according
to the clinical pathway for heart failure was also demonstrated.
Conclusions. The overall purpose of clinical pathways is to improve outcome by providing a mechanism to coordinate care
and to reduce fragmentation, and ultimately cost. Our results demonstrated that it is possible to achieve this goal. Although
controversial elements still exist, we think that clinical pathways can have a positive impact on quality in health care.
Keywords: clinical pathways, clinical variation, continuous quality improvement, evidence-based medicine, health care
processes, integrated care pathways
Variation is a critical element in health care systems. Many
authors agree that the main determinant factors of variation
are the different availabilities of health care services, the
scarce use of medical evidence, and the phenomena of pro-
fessional uncertainties [1–5]. In particular, professional uncer-
tainty and the scarce use of medical evidence seem to be the
key elements in many problems dealing with health care vari-
ations, due to their possible links with medical errors [6]. It
has been estimated that between 44 000 and 98 000 people die
each year from medical errors in the United States [7]. Even if
it is difWcult to establish a direct relationship between vari-
ations and errors, reducing variations by standardizing clinical
processes is an effective tool to minimize the probability of
medical errors [8].
Other than the ethical considerations, variation problems
are especially critical today because the pressure to reduce
health care costs without reducing quality in patient care has
increased. The creation of clinical pathways has become
a popular response to these concerns [9–14].
Clinical pathways (also known as critical pathways, care
maps, integrated care pathways, etc.) are integrated manage-
ment plans that display goals for patients, and provide the
sequence and timing of actions necessary to achieve such
goals with optimal efWciency [15,16].
According to continuous quality improvement principles,
clinical pathways stress the improvement of clinical processes
in order to improve clinical effectiveness and efWciency.
Thus, clinical paths are clinical management tools used by
health care workers to deWne the best process in their organ-
ization, using the best procedures and timing, to treat patients
with speciWc diagnoses or conditions according to evidence-
based medicine (EBM) [17]. As a consequence, the introduc-
tion of clinical pathways could be an effective strategy for
health care organizations to reduce or at least to control their
processes and clinical performance variations [18].
Pathways are an evidence-based response, at both a struc-
tured and a local level, to speciWc problems and care needs,
and for this reason they could have a higher level of compli-
ance compared with other instruments such as practice guide-
lines, which are not based on local professional consensus [19].
They are also developed by multi-professional teams, com-
posed of all types of physicians (from family practitioners to
specialists), nurses, social workers, and administrators, who
manage the disease processes and are responsible for patient
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care [20]. The beneWts are clear: sharing information develops
the learning processes within an organization, helps profes-
sionals to understand their roles and responsibilities better, and
improves integration in all segments of the health care system.
All of these are basic steps to reduce variations [21,22].
Finally, this coordinated and integrated use of multi-
professional working teams could provide effective protection
against the risk of developing a clinical pathway that is led by
only one professional group, which seems to be the best way
to protect against opinion-based variations [23–25].
Despite widespread enthusiasm for clinical pathways,
rigorous evidence to support their beneWts in health care is
limited [26,27]. For this reason we tested clinical pathways in
various Italian health care organizations during the period
2000–2002 in order to measure their performance in decreasing
process and outcome variations.
Methods
Study design and statistical analysis
We constructed a pre- and post-analysis model to evaluate the
effect of applying clinical pathways to process and outcome
indicators, and to the costs sustained to assist patients using
the activity-based costing (ABC) methodology [28]. ABC is
a technique to measure quantitatively the cost and performance
of activities, resources, and cost items. ABC captures organ-
izational costs for the factors of production and applies them
to the deWned activity structure. Costs are allocated based on
interviews with professionals about their activities. ABC is
usually used in comparative analysis because it helps to clarify
the relationship between activities and costs [29].
We set up an experimental period of 1 year for each setting:
6 months before and 6 months after the implementation of
the clinical pathway. The samples included all the patients
treated by staff during the experimental period.
The normality of the distribution for quantitative variables
was veriWed using the Shapiro–Wilks test. We studied each
quantitative variable using the Student’s t-test or Wilcoxon
test, and each qualitative variable using the χ2 test or Fischer
test [30]. We considered P values <0.05 signiWcant, and
P values <0.01 strongly signiWcant. Statistical analysis was
performed using Statistica software (STASOFT).
Development of indicators
A set of indicators was developed to measure the variations
in the care processes (the macro-variations are expressed by
the average and standard deviation (SD) of the length of stay,
and the micro-variations are expressed by the core-process
variations and deviations from the clinical pathways) and in
the outcomes (rates of clinical outcomes).
The clinicians were involved in developing the indicators,
and were basically asked to propose to the research team a set
of process and outcome indicators that were speciWc for each
clinical pathway [31–41]. We evaluated each indicator according
to the following dichotomous criteria: validity (evidence
based or not; the proposed indicator had to be supported by
consistent literature); reliability and feasibility of data collec-
tion (easy or difWcult; data available from current information
systems or from ad hoc databases); comparability (low or
high; internal tracking versus external comparisons of the
results); and relevance (yes or no; according to the strength of
the relationship between the improvement of the indicator
and the improvement for patient/organization outcome or
process).
A rank of priority, determined using the preceding vari-
ables, was assigned to each indicator. According to the rank,
we selected the 10 best indicators for each clinical pathway.
The ultimate set of indicators is reported in the Appendix.
Finally we deWned the procedures for data collection and
analysis. Data were collected by local staff (clinical path teams);
the analysis was performed by the research team. We did not
use incentives for the local staff.
Clinical pathway development
To build the clinical pathways, we merged EBM tools
with business process re-engineering techniques [42–47] as
follows:
1. Select the area of practice. We chose the area with a selection
matrix, including diagnoses, with higher costs, higher volumes,
higher mortality, higher length of stay, or greater number of
outcome variations.
2. Build the multidisciplinary work-team. We involved physi-
cians (from family practitioners to specialists), nurses, thera-
pists, social workers, and administrators providing care in the
selected area.
3. DeWne the diagnosis. We identiWed clinical selection criteria
for each diagnosis with explicit and shared disease-staging
scales.
4. DeWne the patients. We identiWed other selection criteria as
non-clinical, such as socio-economic factor, housing status,
age of the patient, etc.
5. Review practice and literature. We analysed the care pro-
cesses and researched the best evidence for the patients. The
results of this phase came from all the members of the team.
6. Develop the clinical path. We started by deWning the appro-
priate goals to satisfy the multidimensional needs of the
patients (patient focus phase). Next we ‘translated’ the results
from the review phase into elements of care detailed in local
protocols and documentation, including the sequence of
events and expected progress of the patients over time. The
elements of care for each professional were deWned according
to the care categories (Figure 1).
7. Pilot and implement the clinical pathway. We educated the
staff and monitored the use of the pathway. This last step was
carried out by completing data record sheets that summarized
the tasks of each professional during the care of the patients
and the possible deviations from the path.
8. Ongoing evaluation. We assessed the level of completion
of the data recording, investigated why there were any differ-
ences between the one in practice and the recommended
one (deviations from the pathways), and measured patients’
outcomes.
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9. Implementation. The last phase consisted of the daily utili-
zation of the clinical path, its regular monitoring (every
3 months) and updating (yearly).
Results
The overall results are summarized in Table 1. The results of
each clinical pathway are reported below.
The clinical pathway for inguinal hernia repair
The overall sample consisted of 243 patients. Of the 126
patients treated according to the clinical pathway, 71 under-
went day surgery and 55 underwent a 3-day stay. We compared
these data with the results of 117 patients treated before the
implementation of the clinical pathway (Table 2).
After the implementation of the pathway we noticed a
signiWcant increase in day-surgery activity, demonstrating a
more rational use of hospital stays in the unit. As a consequence,
we measured a strong decline in both the average length of
stay and its variation (SD decreased from 2.27 to 1.38 days).
The pathway core processes yielded noticeable beneWts.
The number of exams included in preoperative diagnostic
routine decreased. Antibiotic prophylaxis with clarithromycin
500mg infusion, which was performed without discrimina-
tion prior to pathway implementation (even if not evidence
1. Evaluation of patients’ multidimensional needs;
2. Education of patients and families;
3. Planning of patients’ pathway (through the whole organisation);
4. Planning and execution of diagnostic exams;
5. Execution of interventions or procedures;
6. Activation of specialty consultancies;
7. Management of pharmacological therapy;
8. Management of nutrition;
9. Management of activities and patients’ safety.
Figure 1 Phase of the clinical pathway development: the care
categories.
Table 1 Testing the use of clinical pathways: overall results
NC, not calculable.
1SigniWcant (P < 0.05).
2Strongly signiWcant (P < 0.01).
Clinical 
pathway
Level of 
implementation
Length of 
stay decrease
Core processes 
improvement
Residual 
variations rate
Outcome
improvement
Costs
reduction
................................................................................................................................ .........................................................................................
Inguinal hernia repair Completed Yes2 Yes2 2.22% No Yes1
Stroke Interrupted NC NC 28.20% NC NC
Chronic renal failure Interrupted No NC 15.18% NC NC
Chronic heart failure Completed Yes2 Yes1 5.90% Yes2 No
Total hip replacement Completed No Yes1 13.55% No Yes1
Table 2 The clinical pathway for inguinal hernia repair: comparison of the process indicators before and after the implementation
of the clinical pathway
NA, not available; NS, not signiWcant; NC, not calculable.
Indicators Before (117 cases) After (126 cases) P value
................................................................................................................................ .........................................................................................
Rate of day surgery activity 38.46% 56.35% <0.05
Average length of stay (days) 3.25 1.64 <0.01
Median number of preoperative exams (per patient) 22 7 <0.01
Proportion of patients with antibiotic prophylaxis 
(not consistent with current recommendations)
100.00% 0.00% <0.01
Proportion of patients with correct hair removal 81.19% 100% <0.01
Rate of completion of clinical records 62.39% 95.24% <0.01
Proportion of patients with massive bleeding 0.00% 0.00% NS
Proportion of patients with postoperative pain NA 3.18% NC
Proportion of patients with wound infections 3.42% 2.34% NS
Proportion of patients with unscheduled return
to operating room
1.71% 0.79% NS
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based), was no longer administered. Also, the rate of correct
performance of preoperative hair removal increased signiW-
cantly, as did the percentage of completion of clinical records.
From a strictly clinical perspective, however, we did not
notice any signiWcant differences in patient outcomes
between pre- and post-pathway implementation, as measured
using local or early complication rates, which are the only
ones related to surgical or management error.
We next analysed the causes of the residual variations after
the implementation of the pathway. An interesting reason for
deviations from the pathways was incomplete hospital-
discharge cards for patients. This was due to organizational
problems such as the untimely arrival of the card, on average
3 days after patient admission, when the patient had already
been discharged. Furthermore, the clinical record and the
consent form for the intervention were not completed for
some patients. This happened more frequently with day-
surgery admissions, mostly due to the poor habit/lack of
attention of physicians when Wlling out the clinical documen-
tation, along with the provision of care.
With respect to variations in outcome, we noted 12 ordinary-
stay cases that remained longer than the deWned 3 days, and
four conversions from day surgery to ordinary stay, all of
which were due to very intense postoperative pain, patient
request, or other organizational barriers to getting the patients
home.
Finally, we measured a signiWcant reduction in the average
costs sustained to assist each patient, which dropped from
US$732.94 (approximately 790) to US$445.52 (approxi-
mately 480).
The clinical pathway for strokes
Study regarding the clinical pathway for strokes was
stopped after 3 months, because only the two physicians
who participated in the development of the clinical pathway
accepted using it to manage patient care. Before implemen-
tation of the clinical pathway, patients were treated without
a structured assessment of their conditions, whereas with
the clinical pathway all patients had to be stratiWed according
to the seriousness of the condition at admission and during
the stay. Doctors refused to adopt the clinical pathway
because they considered this process like a ‘cookbook’,
i.e. too simple to treat the heterogeneity of the patients’
conditions. This situation compromised the chance of
implementing the pathway and evaluating its effectiveness
and efWciency.
Due to resistance from doctors, staff were able to treat
only nine of the 35 patients admitted during the period
using the clinical path. Moreover, variance report grids for
core processes showed a residual variation rate of 28.20%
for the patients treated. Also, the documentation was not
Wlled out properly (mostly because medical staff indicated
reasons for the variances in performance in only 2.5% of
cases). For this reason we could not measure any signiWcant
improvement in quality using the process and outcome
indicators.
The clinical pathway for chronic renal failure
During the experimentation period, 26 patients were admitted
but only nine were treated using the clinical pathway. Because
of the small sample we could not observe any signiWcant
changes in process and outcome indicators before and after
the implementation of the pathway.
From a strictly organizational perspective, the main goal of
the pathway was the implementation of a process of pro-
grammed early discharge that could integrate hospital care
with long-term and home care. We deWned protocols for this
purpose but they were adopted for only two patients. We
tried to Wnd the reasons for this using the analysis of variation
grids. Due to the low level of accuracy in completing and read-
ing documents (52.75% of cases), we also interviewed staff.
We could not Wnd any speciWc reasons for failing to
discharge patients early: hospital nurses reported generic inte-
gration difWculties with the other levels of care; doctors com-
plained of their difWculties in adapting the discharge protocols
of the clinical path to the clinical seriousness of, or variations
in, the patients’ clinical conditions. We did not measure any
reductions in costs.
The clinical pathway for heart failure
The sample consisted of 246 patients (43.62% males, average
age 78.9 years). We used New York Heart Association
(NYHA) class scores to classify the severity of patients’ con-
ditions at admission in the emergency room (ER) and in the
general medicine unit (GM), and also at discharge.
We measured a diagnostic agreement between ER and GM in
77.78% of cases (heart failure versus other diagnoses). After
stratiWcation according to the patients’ NYHA scores, agreement
dropped to 54.41% of cases; in the ER, 22.06% of subjects
received a NYHA class of less seriousness than assigned in the
GM (one patient with NYHA II, eight patients with NYHA III,
and six patients with NYHA IV) and 5.88% were misclassiWed as
too serious (four patients with NYHA III).
We should note that we planned hospital admissions for
patients with NYHA III–IV scores only. Nevertheless, we
also admitted patients with NYHA II scores because of their
social conditions (old people alone in their houses, residences
very far from the hospital, etc.).
After the implementation of the clinical path we observed
a signiWcant improvement in the quality of the clinical core
processes (left ventricular assessment, smoking cessation
counselling, discharge instructions, etc.). Results are shown in
Table 3. Moreover, we observed a signiWcant improvement in
the outcomes: we reduced both total admissions (from 178 to
68 cases) and unscheduled readmissions. The most signiWcant
result was the reduction in in-patient mortality with respect to
class of severity of patient condition, as determined at admis-
sion (Figure 2). As also shown in Figure 2, before the path-
way, we observed a high outcome variation in all cases,
independent of patient disease-staging. Outcome variation
was reduced after implementation of the pathway. Costs,
however, did not decrease after the implementation of the
pathway.
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The clinical pathway for total hip replacement
Results are reported in Table 4 and are based on a sample of
100 patients (43 patients before and 57 patients after imple-
mentation of the clinical pathway).
We did not observe any differences in the length of stay
compared with the preceding situation. On the contrary, the
most signiWcant result was in the variation between pre- and
post-admission patient paths. The pre-intervention diagnostic
path was simpliWed into a single visit, whereas previously the
pathway patients required four separate visits to three different
facilities: an initial anaesthesiology visit, laboratory exams,
a cardiology visit, and a second anaesthesiology visit. The
post-intervention path improved for all patients who received
follow-up appointments periodically (follow-ups at 1 month,
3 months, 6 months, 1 year, and 2 years after the intervention).
We measured similar improvement in the quality of the
core processes after the implementation of the clinical path-
way. The compliance with analgesic therapy increased, as well
as the rate of erythropoietin administration. The number of
laboratory exams included in the diagnostic routine
decreased. Moreover, we measured a signiWcant improvement
in the appropriateness of the use of diagnostic technologies
(Figure 3). We reduced the indiscriminate pre-intervention
use of carotid arteries echodoppler and echocardiograms
Table 3 The clinical pathway for heart failure: comparison of the process indicators before and after the implementation of
the clinical pathway
NA, not available; NC, not calculable; NS, not signiWcant; ACE, angiotensin-converting enzyme.
Indicators Before (178 cases) After (68 cases) P value
................................................................................................................................ ........................................................................................
Rate of diagnostic agreement between emergency room
and general medicine unit
NA 77.78% NC
Average length of stay (days) 10.89 7.96 <0.01
Rate of completion of clinical records in emergency room 21.71% 26.29% NS
Rate of completion of clinical records in general medicine unit 26.29% 62.86% <0.01
Proportion of patients with left ventricular function assessment 44.94% 100.00% <0.01
Proportion of smoker patients with advice/counselling
for smoking cessation
NA 100.00% NC
Proportion of patients with written discharge instructions
(activity, diet, etc.)
0.00% 100.00% <0.01
Proportion of patients with ACE inhibitor at discharge 12.36% 20.59% NS
Rate of unscheduled readmissions within 31 days 6.74% 2.94% NS
Total in-patient mortality 17.42% 4.41% <0.01
Table 4 The clinical pathway for total hip replacement: comparison of the process indicators before and after the implemen-
tation of the clinical pathway
NS, not signiWcant; NA, not available; NM, not measurable; NC, not calculable; FIM, functional independent measure.
Indicators Before (43 cases) After (57 cases) P value
................................................................................................................................ .........................................................................................
Average length of stay (days) 13.07 12.81 NS
Average diagnostic accesses of the patients
(No. per patient)
3.50 1.00 <0.05
Median of preoperative exams (No. per patient) 32 14 <0.05
Proportion of patients compliant with
preoperative analgesic therapy
9.30% 42.11% <0.01
Proportion of patients with preoperative
administration of erythropoietin
30.23% 68.42% <0.01
Proportion of patients with antibiotic prophylaxis
consistent with current recommendations
20.93% 40.35% <0.05
Proportion of patients with complete follow up 51.16% 100.00% <0.01
Proportion of patients with early complications 0.00% 0.00% NS
Proportion of patients with late complications NA NM NC
Average level of residual disability at follow up (FIM scale) NA NM NC
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(P < 0.01), and direct chest radiography was limited to subjects
who had not had an X-ray in the preceding 6 months. We did
not change the rate of cardiology consultations and electrocar-
diograms, which were still performed on all subjects due to
medical/legal concerns. In addition, radiological exams done
on limbs to be operated on were reduced from 4.61 to 2.58
(P < 0.05).
Variation grids showed that we were not successful in
adopting the correct prophylaxis for surgical site infections.
Basically, there was already a protocol in use, even though
it differed from recommendations. For this reason, and con-
sidering that it was impossible to substitute this protocol
immediately, which was deep-rooted in the physicians’ habits,
we decided to (i) back it up with a second one, which was
Before clinical pathway implementation
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Figure 2 The clinical pathway for heart failure: comparison of patients’ conditions at admission and discharge, before and after
the implementation of the clinical pathway. The analysis was performed using the New York Heart Association scores
(NYHA) attributed to the patients by the cardiologists in the General Medicine (GM) unit.
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evidence based and less expensive, and (ii) to evaluate any
differences in effectiveness (no infections were reported with
either scheme).
Only short-term outcomes are currently available, and do
not highlight any differences compared with the situation
before the introduction of the clinical pathway. We observed
a reduction in costs of ∼25%.
Discussion
Our primary Wnding was that the implementation of the clin-
ical pathway for heart failure reduced in-patient mortality and
outcome variations. We observed also a signiWcant improve-
ment in the quality of almost all clinical processes after the
development of our clinical pathways: current practice was
reviewed and the most recent evidence was incorporated.
Pathways were helpful for clinical risk management. Our
results also showed that this was possible without increasing
costs; in fact, on the contrary, we observed a signiWcant
reduction in the costs of assisting patients treated according
to the clinical pathways for inguinal hernia repair and total hip
replacement. We also observed some major failures: the clinical
pathways for strokes and chronic renal failure were not
helpful, and their implementation was discontinued.
We tried to analyse the above results by addressing the
main issue to arise from this research: were these results
achieved through the pathways or through the way these tools
were applied? Clinical pathways must be used as tools in an
overall quality improvement plan to meet speciWc patient
population needs in all settings. Unfortunately, Wnding the
proper balance between clinician autonomy and standardiza-
tion has proved difWcult. Many doctors still consider clinical
pathways as ‘cookbook medicine’, even though they could
change the pathway for a patient at any time [10]. On the con-
trary, they sometime refuse to change their routines even
when they have been proved to be ineffective.
We tried to solve these problems by creating constant dia-
logue within the team, between clinicians and managers.
A good tool suited to this purpose was the analysis of variance
grids. When the team examined variance sheets regularly, it
was possible to identify common reasons why the clinical
path was not followed. According to other studies this can
lead to discussion within the team, which then facilitates full
implementation of the clinical pathway [20]. When it was
impossible to create such a dialogue, the implementation of
the pathways failed.
In our experience, quantiWcation of outcomes can provide
the key to an effective dialogue with clinical teams, because
outcome assessment provides reports that are easy to use by
health care professionals that will support clinical decision
systems [48]. However, we encountered many difWculties as
a result of current information systems.
A signiWcant barrier to measuring and improving outcome
indicators was found to be the method of documenting and
collecting data from current sources (e.g. clinical records,
hand-written abstraction tools, and variance grids). We think
that with a more comprehensive information structure for
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Figure 3 The clinical pathway for total hip replacement: use of the pre-intervention exams before and after the implementation
of the clinical pathway.
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our pathways, implementation would be easier. In future pro-
grammes we intend to develop information systems that will
provide automatic abstraction tools: this could increase the
efWciency of reporting compliance with the indicators of the
pathways. We believe that by saving hours of charting every
day using computerized documentation and data collection,
we can signiWcantly improve physicians’ attitudes towards
clinical paths.
The incorporation of incentives for compliance with clin-
ical pathways into staff performance appraisals and physician
credentialing should have been explored. Even though good
results were achieved with clinical paths in many areas, they
probably could have been better had incentives been offered.
Despite this, we observed in all the settings that the main
determinant of success was the level of involvement of all
health care providers in the development of the pathways. If
clinicians are not the key players in this process, there is a real
danger that the clinical path could be considered an adminis-
trative attempt to reduce costs, and therefore it would most
likely fail [16]. This probably happened to the clinical path-
ways for strokes and renal failure.
The overall purpose of clinical pathways is to provide
better care through a mechanism that is able to coordinate
clinical processes and to reduce unjustiWed variations and,
ultimately, costs. During this research it became apparent that
teams should be educated more thoroughly with this purpose
in mind, particularly physicians. The people involved in the
implementation of the pathways are clinicians. They are less
well educated about concepts such as ‘the market’, ‘the organi-
zation’, ‘managed care’ etc., and, following our research, we
think that this type of education would have enhanced the
implementation of our clinical pathways, resulting in greater
success [49].
This study also has important limitations. The initial
measurement occurred a year before the full implementation
of the pathways. Thus, it is possible that some of the observed
improvement represented a natural drift toward higher per-
formance. Moreover, the comparison of the indicators before
and after the adoption of the clinical pathways may have been
distorted by the lack of attention while collecting data before
pathway implemention. A longer implementation period and
the adoption of a different study design, such as a randomized
controlled trial, might have improved the strength of our
Wndings. However, we observed signiWcant improvements in
different groups of patients, with different diagnoses, in dif-
ferent settings: this suggests that the implementation of the
clinical pathways did have an impact on the quality of care.
Patient satisfaction was not measured, which is a serious
study limitation. Combining clinical indicators with a satisfac-
tion survey could have given a more accurate measure of the
real level of quality achieved through clinical pathways [19].
Neither was the cost of the development and implementation
of the pathways evaluated. Although some pathways reduced
length of stay or cut costs for diagnostic exams, etc., we can
not conclude that the implementation of a clinical path is a
cost-effective process. This issue becomes critical for the clin-
ical pathways that have not been shown to improve care, such
as the paths for strokes and renal failure: how should health
care organizations respond to clinical paths when they fail?
Further research is needed to answer this question [26].
Since many environmental factors may be determinants of
the effectiveness of the clinical pathways, health care organi-
zations should evaluate their institutional circumstances
carefully before implementing them. In some instances the
removal of other barriers to provision of care may be more
effective, which would seem to be the basic goal before starting
the development of clinical pathways [50].
Finally we implemented hospital-based clinical paths. Cur-
rent trends suggest that pathways should be extended into
primary care and community settings. The next step in our
research will be the development of more highly integrated
pathways that span the continuum of care for our patients.
In conclusion, this research provides further evidence of
the value of clinical pathways. Some clinical pathways
appeared to be effective in reducing unnecessary variations
and in improving the outcomes and the quality of the care
provided to patients. Also, the adoption of clinical pathways
added permanent value to organizations as a whole: pathways
supported and reinforced risk management, management by
objectives, and utilization management, and also helped to
promote EBM and the practice of evaluating. We believe that
this is the real value that clinical pathways can add to the quality
of modern medicine.
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Appendix: the clinical pathways indicator set
Clinical pathway Indicator Typology Criterion met/expected change Measure
............................................................................................................................................................................................................................................................................................................
Inguinal hernia repair Average length of stay Process SigniWcant reduction in pre–post comparison
(P < 0.05)
No. of days
Rate of day surgery activity Process SigniWcant improvement in pre–post comparison
(P < 0.05)
Percentage
Median of preoperative exams Process SigniWcant reduction in pre–post comparison
(P < 0.05)
No. per patient
Proportion of patients with antibiotic prophylaxis
consistent with current recommendations
Process No patients given prophylactic antibiotics
(prophylaxis is not recommended)
Percentage
Proportion of patients with correct hair removal Process Hair removal with disposable head shaver
given to all the patients
Percentage
Rate of completion of clinical records Process At least 80% of clinical records must
be fully Wlled up
Percentage
Proportion of patients with massive bleeding Outcome No patients with massive bleeding Percentage
Proportion of patients with postoperative pain Outcome No patients with postoperative pain Percentage
Proportion of patients with wound infections Outcome <3% of patients with wound infections Percentage
Proportion of patients with unscheduled return
to operating room
Outcome No patients with unscheduled return
to operating room
Percentage
Stroke Proportion of patients with length of stay
>2 hours in emergency room
Process No patients with length of stay  >2 hours
in emergency room
Percentage
Average length of stay Process SigniWcant reduction in pre–post comparison
(P < 0.05)
No. of days
Proportion of patients with early rehabilitation
(within 3 days from acute event)
Process At least 90% of patients must receive
early rehabilitation
Percentage
Proportion of patients treated with nifedipine Process SigniWcant reduction in pre–post comparison
(P < 0.05)
Percentage
Proportion of patients with warfarin
at discharge
Process SigniWcant improvement in pre–post comparison
(P < 0.05)
Percentage
Proportion of patients with antithrombotic
at discharge
Process SigniWcant improvement in pre–post comparison
(P < 0.05)
Percentage
Rate of completion of clinical records Process At least 80% of clinical records must
be fully Wlled up
Percentage
Proportion of patients with unscheduled
return to intensive care unit
Outcome SigniWcant reduction in pre–post comparison
(P < 0.05)
Percentage
Proportion of patients with improved Barthel
Index at discharge
Outcome SigniWcant improvement in pre–post comparison
(P < 0.05)
Percentage
Total in-patient mortality Outcome SigniWcant reduction in pre–post comparison
(P < 0.05)
Percentage
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Clinical pathway Indicator Typology Criterion met/expected change Measure
............................................................................................................................................................................................................................................................................................................
Chronic renal failure Average length of stay Process SigniWcant reduction in pre–post comparison
(P < 0.05)
No. of days
Levels of appropriateness of the stay
with AEP protocol
Process SigniWcant improvement in pre–post comparison
(P < 0.05)
Percentage
Proportion of patients with temporary access at
the Wrst dialysis
Process SigniWcant improvement in pre–post
comparison (P < 0.05)
Percentage
Proportion of patients with permanent catheters
in dialysis population
Process SigniWcant improvement in pre–post
comparison (P < 0.05)
Percentage
Proportion of patients with infection to
arteriovenous Wstula
Process Rate of infection must be < 5% Percentage
Rate of completion of clinical records Process At least 80% of clinical records must
be fully Wlled up
Percentage
Proportion of patients with discharge instructions
(activity, diet, etc.)
Process SigniWcant improvement in pre–post comparison
(P < 0.05)
Percentage
Proportion of patients with programmed discharge Process Programmed discharge given to all patients
needing it
Percentage
Minimum success rate (MSR) in dialysis patients Outcome SigniWcant improvement in pre–post comparison
(P < 0.05)
MSR score
Total in-patient mortality Outcome SigniWcant reduction in pre–post comparison
(P < 0.05)
Percentage
Heart failure Rate of diagnostic agreement between emergency
room and general medicine unit
Process Agreement good (60 < κ < 80) Cohen’s kappa
Average length of stay Process SigniWcant reduction in pre–post comparison
(P < 0.05)
No. of days
Rate of completion of clinical records in
emergency room
Process At least 80% of clinical records must
be fully Wlled up
Percentage
Rate of completion of clinical records in
general medicine unit
Process At least 80% of clinical records must
be fully Wlled up
Percentage
Proportion of patients with left ventricular
function assessment (LVFA)
Process LVFA given to all patients before arrival, during
the stay or  planned for after discharge
Percentage
Proportion of smoker patients with advice/
counselling for smoking cessation
Process Advice or counselling during the stay given to all
patients  with a history of smoking
Percentage
Proportion of patients with written discharge
instructions addressing: activity level, diet,
discharge medications, follow up, weight
monitoring, and what to do if symptoms worsen
Process Written discharge instructions/educational
material given to  all patients
Percentage
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FIM, functional independent measure; AEP, appropriateness evaluation protocol; Hct, hematocrit.
Appendix continued
Clinical pathway Indicator Typology Criterion met/expected change Measure
............................................................................................................................................................................................................................................................................................................
Proportion of patients with ACE inhibitor
(ACEI) at discharge
Process ACEI given to all patients (without
contraindications) with  left ventricular
function <40%
Percentage
Rate of unscheduled readmissions within 31 days Outcome SigniWcant reduction in pre–post comparison
(P < 0.05)
Percentage
Total and speciWc in-patient mortality (stratiWcation
according to severity of patient’s condition
at admission measured with New York
Heart Association score)
Outcome SigniWcant reduction in pre–post comparison
(P < 0.05)
Percentage
Total hip replacement Average length of stay Process SigniWcant reduction in pre–post comparison
(P < 0.05)
No. of days
Average diagnostic accesses of the patients Process SigniWcant reduction in pre–post comparison
(P < 0.05)
No. per patient
Median of preoperative exams Process SigniWcant reduction in pre–post comparison
(P < 0.05)
No. per patient
Proportion of patients compliant with
preoperative analgesic therapy
Process SigniWcant improvement in pre–post comparison
(P < 0.05)
Percentage
Proportion of patients with preoperative
administration of erythropoietin
Process Erythropoietin given to all patients with
Hct <37
Percentage
Proportion of patients with antibiotic prophylaxis
consistent with current recommendations
Process Antibiotic prophylaxis with cefazolin,
cefuroxime, or  vancomycin given
to all patients
Percentage
Proportion of patients with early complications Outcome Wound infections <3%, intraoperative
fractures <3%,  nervous-vascular lesions 0%
Percentage
Proportion of patients with late complications Outcome Prosthesis removal within 2 years from
discharge <2%
Percentage
Average level of residual disability at follow up Outcome Patient improvement at FIM FIM scale
Proportion of patients with complete follow up Process All patients must accomplish
follow up process
Percentage
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